Revance Therapeutics shares owned by Rafferty Asset Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Rafferty Asset Management
from 13F filings
Historical chart of Rafferty Asset Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Rafferty Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $235k | 21k | 11.47 |
| 2023-06-30 | $228k | 9.0k | 25.31 |
| 2023-03-31 | $227k | 7.0k | 32.21 |
| 2022-12-31 | $232k | 13k | 18.46 |
| 2022-06-30 | $177k | 13k | 13.84 |
| 2021-12-31 | $240k | 15k | 16.30 |
| 2021-09-30 | $217k | 7.8k | 27.82 |
| 2020-12-31 | $224k | 7.9k | 28.31 |